蛋白质聚合:后果,机制,表征和抑制策略
Nabeela Majid1, Rizwan Hasan Khan1
1Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh 202002, India.
International journal of biological macromolecules
|June 3, 2023
概括
蛋白质错误折叠和聚合导致神经退行性疾病,如阿尔茨海默病和帕金森病. 目前的治疗方法具有症状性,这突显了针对蛋白质聚合的根本原因的治疗方法的需要.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 神经科学是一个神经科学.
背景情况:
- 蛋白质对于细胞功能至关重要,但在改变的环境条件下,蛋白质可以错误折叠和聚合.
- 蛋白质聚合压倒了细胞质量控制系统 (ubiquitin-proteasomal机器和自),导致毒性.
- 错误折叠的蛋白质,如粉样β和α-synuclein与阿尔茨海默氏症和帕金森症等疾病有关.
研究的目的:
- 审查蛋白质错误折叠和聚合的基本机制.
- 讨论当前的治疗策略,并确定治疗蛋白质错折疾病的差距.
- 为神经科学和相关领域的研究人员提供全面的资源.
主要方法:
- 关于蛋白质误折叠和聚合的文献综述.
- 细胞质量控制途径的分析.
- 检查与疾病相关的蛋白质聚合机制.
- 对现有和假设的治疗干预措施的调查.
主要成果:
- 蛋白质错误折叠和聚合是主要神经退行性疾病的病原体的核心.
- 现有的治疗方法可以缓解症状,但不能解决蛋白质聚合的根本原因.
- 对于针对启动蛋白质聚合的新疗法存在着极大的需求.
结论:
- 了解蛋白质错误折叠和聚合对于开发有效的疾病修饰疗法至关重要.
- 针对蛋白质聚合的初始步骤对于治疗神经退行性疾病具有前景.
- 本综述巩固了知识,以指导未来的研究,开发对蛋白质病变的致病治疗方法.
相关概念视频
Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K
Protein-protein Interfaces
12.6K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.6K
Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.9K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.9K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
608
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
608
Molecular Chaperones and Protein Folding
18.1K
The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
The...
18.1K
The Proteasome
914
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
914


